Related Experiment Video
Updated: Aug 19, 2025

09:06
Cochlear Implant Surgery and Electrically-evoked Auditory Brainstem Response Recordings in C57BL/6 Mice
Published on: January 9, 2019
14.0K
Long term behavior of dexamethasone-loaded cochlear implants: In vitro & in vivo
T Rongthong1, A Qnouch1, M Maue Gehrke1
1Univ. Lille, Inserm, CHU Lille, U1008, F-59000 Lille, France.
International Journal of Pharmaceutics: X
|December 5, 2022
Summary
This study investigated long-term dexamethasone release from silicone cochlear implants. Results show reliable drug control over years, crucial for treating hearing loss.
Area of Science:
- Biomaterials Science
- Drug Delivery Systems
- Otolaryngology
Background:
- Silicone-based cochlear implants offer potential for local, controlled dexamethasone delivery to treat hearing loss.
- Achieving very long drug release periods (years/decades) for these implants presents significant product optimization challenges.
- Limited knowledge exists regarding the long-term behavior of these systems, including drug release kinetics and dimensional stability.
Purpose of the Study:
- To evaluate the long-term in vitro and in vivo behavior of silicone-based cochlear implants loaded with dexamethasone.
- To understand drug release patterns, swelling/shrinking properties, and the underlying mechanisms.
- To assess the feasibility of predicting long-term drug release for product optimization.
Main Methods:
- Cylindrical cochlear implants with varying dimensions and dexamethasone loading (0-10%) were fabricated via injection molding.
- In vitro drug release was monitored in artificial perilymph at 37°C for over 3 years.
- Implants were characterized using optical microscopy, X-ray diffraction, and Raman imaging before and after in vitro/in vivo (2 years in gerbils) exposure.
Main Results:
- Dexamethasone release was reliably controlled throughout the study periods (>3 years in vitro, 2 years in vivo).
- Diffusional mass transport and drug solubility within the silicone matrix were identified as key factors governing release.
- No significant swelling or shrinking of the implants was observed in vitro or in vivo.
Conclusions:
- Silicone-based cochlear implants demonstrate reliable long-term dexamethasone release, supporting their potential for hearing loss treatment.
- A simplified mathematical model can aid in predicting long-term drug release rates, facilitating implant design and optimization.
- Understanding drug diffusion and solubility is critical for developing advanced, long-duration drug delivery systems.

